Benzinga | Mar 1, 2021 07:03AM EST

Axsome Therapeutics Q4 EPS $(0.78) Misses $(0.76) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.78) per share which missed the analyst consensus estimate of $(0.76) by 2.63 percent. This is a 9.86 percent decrease over losses of $(0.71) per share from the same period last year.